Renata Guerra

- 11 years of experience in Pharmaceutical Market;
- Product Manager since 2007;
- Experience in Primary & Specialty Care Segments.

Graduated in Market Communication (Marketing / Promotion & Advertising) from UMESP – SP & Product Management Specialization from FGV – SP. I was hired by AstraZeneca in 2003 as CRESTOR’s Trainee to support the rosuvastatin launch in Brazil. As soon as I graduated (2004) I got a promotion to Advertising Analyst. In 2006 I was invited to coordinate the Mature Products Line, represented by different brands in 03 distinct segments. After this experience I was promoted to SELOZOK Product Manager (2007) . At the beginning of 2010 I received another invite to manage CRESTOR – the 1st brand of Ethical Market before LOE scenario. I was also responsible to launch CRESTOR 5MG in Brazil (Communication strategy focus on different patient profile at CV risk) during LOE scenario through Mackinsey partnership in order to evaluate broad access to extend the product cycle management to middle class market. In 2011 I received a challenge to be responsible for BRILINTA – Oral Antiplatelet launched by AstraZeneca. Since April 2015 (on returning of maternity leave) I’m charge of Respiratory brands.

Overview of portfolio I’m charge of:

Since April 2015

• Symbicort Inhaler | Vannair (Budesonide / Formoterol Fumarate Dihydrate – Inhalation Aerosol) & Pulmicort (Budesonid)

LABA (Long -acting beta2 –adrenergic agonists) and Corticosteroid | Respiratory Segment

2011 - 2015

• Brilinta (Ticagrelor)

Oral Antiplatelet | Primary & Specialty Care Segments

2010 - 2011

• Crestor (Calcic Rosuvastatin)

Statin | Primary Care Segment

2007 - 2010

• Selozok (Metoprolol Succinate) & Seloken (Metoprolol Tartrate)

B-Blockers | Primary Care Segment

2006 - 2007

• Atenol (Atenolol) & Tenoretic (Atenolol + Chlorthalidone)

Antihypertensives | Primary Care Segment

•Zestril (Lisinopril)

ACE Inhibitor | Primary Care Segment

•Zomig (Zolmitriptan)

Oral Triptan | Primary & Specialty Care Segments

•Losec & Losec Mups (Omeprazole)

Oral PPI | Primary Care Segment